Table 3.
Factors associated with complete sputum smear monitoring at unadjusted and adjusted analysis
| Modified Poisson regression analysis | |||||
|---|---|---|---|---|---|
| Variable | Level | Unadjusted analysis | Adjusted analysis | ||
| RR | 95% CI | aRR | 95% CI | ||
| Lives in the same sub-county as the health facility | No | 1 | |||
| Yes | 0.74 | (0.53–1.02) | |||
| Residence | Rural | 1 | 1 | ||
| Urban | 1.17 | (0.87–1.57) | 1.45* | (1.12–1.90) | |
| Type of DOTS | Facility-based | 1 | |||
| Community-based | 2.39*** | (1.60–3.58) | 1.91** | (1.25–2.92) | |
| Persons with TB/HIV | No | 1 | 1 | ||
| Yes | 0.36*** | (0.24–0.53) | 0.45*** | (0.30–0.68) | |
| Health facility ownership | Private-not-for Profit | 1 | |||
| Government | 6.75 | (0.99–45.96) | |||
| Treatment supporter | No | ||||
| Yes | 1.53 | (0.98–2.40) | 1.21 | (0.78–1.88) | |
1) Statistical significance codes at 5%: *p < 0.05, **p < 0.01, ***p < 0.001; 2) DOTS: Directly observed therapy short course strategy; 3) RR: Unadjusted risk ratio; 4) aRR: Adjusted risk ratio